Compare FTCI & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTCI | TKNO |
|---|---|---|
| Founded | 2017 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.4M | 138.1M |
| IPO Year | 2021 | 2021 |
| Metric | FTCI | TKNO |
|---|---|---|
| Price | $4.53 | $2.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $10.80 | N/A |
| AVG Volume (30 Days) | ★ 146.0K | 141.7K |
| Earning Date | 03-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $47,355,000.00 | $40,520,000.00 |
| Revenue This Year | $89.54 | $8.27 |
| Revenue Next Year | $36.35 | $13.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $2.13 | $1.91 |
| 52 Week High | $12.75 | $7.48 |
| Indicator | FTCI | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 32.42 | 54.65 |
| Support Level | $4.07 | $1.97 |
| Resistance Level | $5.20 | $5.39 |
| Average True Range (ATR) | 0.54 | 0.21 |
| MACD | 0.05 | 0.07 |
| Stochastic Oscillator | 13.30 | 69.64 |
FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.